TCTR20200408006招募中4 期
Prospective study effect of leukotriene receptor antagonist add on therapy in asthma : pilot study
Faculty of medicine CM0 个研究点目标入组 40 人开始时间: 2020年4月8日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Clinical diagnosed asthma
- •age >= 18 year
- •Treated with low to moderate dose of ICS/LABA
- •Not well control asthma (ACT score < 20 or physician diagnosed as not well controlled asthma
排除标准
- •History of severe exacerbation including hospitalization / ER visit in the precious year.
- •Pregnancy or child bearing.
- •Subjects who were treated with systemic steroid in the previous 6 months.
- •Subjects who were treated with LAMA.
- •Subjects who were treated with montelukast in the last 3 months.
- •age >= 80 years
研究者
相似试验
已完成
不适用
A comparison study of leukotriene receptor antagonist plus topical nasal steroid versus oral antihistamine + topical nasal steroid versus leukotriene receptor antagonist + oral antihistamine + topical nasal in the treatment of perennial allergic rhinitisRespiratory: Allergic rhinitisRespiratoryPerennial allergic rhinitisISRCTN02329306Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)60
已完成
4 期
Research study of QOL with leukotriene receptor antagonist ,pranlukast in asthmatic patients by use of Asthma Health Questionnaire-Japan QOL (AHQ-JAPAN QOL)AsthmaJPRN-UMIN000000724Asthma QOL Research Study Group1,500
已完成
4 期
Clinical effect of luekotriene receptor antagonist on provocation symptom induced by Japanese cedar pollene antigen disc and grope for clinical marker of nasal obstractioJapanese cedar pollinosisJPRN-UMIN000001362Faculity of Medicine, University of Fukui60
已完成
不适用
Antiremodeling effect of leukotriene receptor antagonist (pranlukast) in asthmatic subjects with chronic airflow limitation as assessed with computed tomography (CT).asthmaJPRN-UMIN000000789Kyoto University Hospitaly30
进行中（未招募）
1 期
The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endothelial function in patients undergoing endovascular treatment due to peripheral arterial disease.Ischemia of the lower limbs in the course of obstructive artery diseaseMedDRA version: 21.1Level: LLTClassification code: 10067825Term: Peripheral arterial disease Class: 10047065CTIS2024-511894-32-00niwersytet Jagiellonski Collegium Medicum200